Monthly Archives: May 2013

Breakthrough Therapy Opens Door to Streamlined Drug Development

2020-02-28T16:03:12+00:00May 15th, 2013|Categories: Blog|Tags: , , |

The FDA's New Breakthrough Therapy Designation The FDA recently added a new designation, ‘Breakthrough Therapy’, to its roster of pharmaceutical regulatory terminology in order to ensure that truly innovative compounds get to the patients who need them most as soon as possible.  This new designation was enacted as part of the 2012 FDA Safety and Innovation Act (FDASIA).  The Breakthrough Therapy designation will provide companies with the opportunity for [...]

Heads up for ASCO: Our List of Key Oncology Presentations

2020-03-02T20:08:35+00:00May 7th, 2013|Categories: News|Tags: |

Expect the biggest data dump of the year at this annual cancer mega-conference For those of us taking an interest in Biotech and Drug Development the largest release of new clinical data is just around the corner at the annual American Society of Clinical Oncology (ASCO) meeting to be held in Chicago starting on May 31. In ASCO’s preliminary press release, the organization revealed what it thought were the key presentations [...]

Comments Off on Heads up for ASCO: Our List of Key Oncology Presentations